Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kira-Lee Koster

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Translational Lung Cancer Research|March 21, 2025
Light on the horizon for HER2 overexpressing non-small cell lung cancer?Kira-Lee Koster, Martin Früh
Exploration of Targeted Anti-Tumor Therapy|September 1, 2022
New antibody-drug conjugates (ADCs) in breast cancer-an overview of ADCs recently approved and in later stages of developmentKira-Lee Koster, Jens Huober, Markus Joerger
Scientific Reports|November 2, 2023
Author Correction: Patient-reported perioperative anaesthesia-related anxiety is associated with impaired patient satisfaction: a secondary analysis from a prospective observational study in SwitzerlandCorina Bello, Matthias Nuebling, Kira-Lee Koster, et al.
Scientific Reports|September 28, 2023
Patient-reported perioperative anaesthesia-related anxiety is associated with impaired patient satisfaction: a secondary analysis from a prospective observational study in SwitzerlandCorina Bello, Matthias Nuebling, Kira-Lee Koster, et al.
European Urology|March 6, 2025
T-Cell Engagers in Prostate Cancer: Promise, Challenges, and the Road AheadTarek Taha, Kira-Lee Koster, Johann S de Bono
Cancer Management and Research|July 29, 2024
Combination Therapy with Immune Checkpoint Inhibitors and Histone Deacetylase Inhibitors or Alkylating AgentsMarkus Joerger, Kira-Lee Koster, Tomas Janik, et al.
Case Reports in Oncology|September 26, 2022
Sotorasib Shows Intracranial Activity in Patients with <i>KRAS G12C-</i>Mutated Adenocarcinoma of the Lung and Untreated Active Brain MetastasesKira-Lee Koster, Christina Appenzeller, Arno Lauber, et al.
International Journal of Molecular Sciences|June 19, 2024
Prolonged Response to Afatinib and Crizotinib in a Rare Case of <i>EGFR</i>-, <i>HER2</i>-, <i>MET</i>- and <i>ROS1</i>-Alterated Lung AdenocarcinomaEva Plomer, Martin Früh, Arno Lauber, et al.
Journal of Inherited Metabolic Disease|June 27, 2014
Functional studies of 18 heterologously expressed medium-chain acyl-CoA dehydrogenase (MCAD) variantsKira-Lee Koster, Marga Sturm, Diran Herebian, et al.
BJU International|December 5, 2022
Case of the month from the Cantonal Hospital, St Gallen, Switzerland: checkpoint inhibition for recurrent prostate cancerKira-Lee Koster, Valentin Zumstein, Krisztian Süveg, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Translational Lung Cancer Research|March 21, 2025
Light on the horizon for HER2 overexpressing non-small cell lung cancer?Kira-Lee Koster, Martin Früh
Exploration of Targeted Anti-Tumor Therapy|September 1, 2022
New antibody-drug conjugates (ADCs) in breast cancer-an overview of ADCs recently approved and in later stages of developmentKira-Lee Koster, Jens Huober, Markus Joerger
Scientific Reports|November 2, 2023
Author Correction: Patient-reported perioperative anaesthesia-related anxiety is associated with impaired patient satisfaction: a secondary analysis from a prospective observational study in SwitzerlandCorina Bello, Matthias Nuebling, Kira-Lee Koster, et al.
Scientific Reports|September 28, 2023
Patient-reported perioperative anaesthesia-related anxiety is associated with impaired patient satisfaction: a secondary analysis from a prospective observational study in SwitzerlandCorina Bello, Matthias Nuebling, Kira-Lee Koster, et al.
European Urology|March 6, 2025
T-Cell Engagers in Prostate Cancer: Promise, Challenges, and the Road AheadTarek Taha, Kira-Lee Koster, Johann S de Bono
Cancer Management and Research|July 29, 2024
Combination Therapy with Immune Checkpoint Inhibitors and Histone Deacetylase Inhibitors or Alkylating AgentsMarkus Joerger, Kira-Lee Koster, Tomas Janik, et al.
Case Reports in Oncology|September 26, 2022
Sotorasib Shows Intracranial Activity in Patients with <i>KRAS G12C-</i>Mutated Adenocarcinoma of the Lung and Untreated Active Brain MetastasesKira-Lee Koster, Christina Appenzeller, Arno Lauber, et al.
International Journal of Molecular Sciences|June 19, 2024
Prolonged Response to Afatinib and Crizotinib in a Rare Case of <i>EGFR</i>-, <i>HER2</i>-, <i>MET</i>- and <i>ROS1</i>-Alterated Lung AdenocarcinomaEva Plomer, Martin Früh, Arno Lauber, et al.
Journal of Inherited Metabolic Disease|June 27, 2014
Functional studies of 18 heterologously expressed medium-chain acyl-CoA dehydrogenase (MCAD) variantsKira-Lee Koster, Marga Sturm, Diran Herebian, et al.
BJU International|December 5, 2022
Case of the month from the Cantonal Hospital, St Gallen, Switzerland: checkpoint inhibition for recurrent prostate cancerKira-Lee Koster, Valentin Zumstein, Krisztian Süveg, et al.
Pageof 3